Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by Law.com, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!

X

More On

Case claims Johnson & Johnson knew about hip implant defects before recall

Loren Kransky is seeking millions of dollars in damages for suffering related to an allegedly faulty hip

In the wake of Johnson & Johnson’s 2010 recall of its ASR artificial hip implants, the company was slammed with more than 10,000 lawsuits. Loren Kransky’s was the first to make it to court.

In closing arguments on Thursday, Kransky’s lawyers argued that J&J’s DePuy unit knew about the artificial hip’s defects when Kransky had one implanted in 2007. He claims that metal debris shed from the implant, poisoning his tissues and causing pain.

J&J argued that there was no medical consensus on what levels of the metals—chromium and cobalt—would damage patients.

"Ultimately the product did not perform as DePuy wanted it to perform or expected it to perform," said J&J lawyer Michael Zellers.

Kransky is seeking $5 million for the suffering he underwent, and up to $179 million in punitive damages.

Read more at Thomson Reuters.

 

For more coverage of the healthcare industry on InsideCounsel, see below:

Court denies contraception coverage injunction

Employers can control health care costs with alternative approaches

Government investigates J&J’s hip devices, surgical mesh

Johnson & Johnson will pay $63 million in Motrin case

Health care fraud probe pays off: U.S. recovers billions

Join the Conversation

Advertisement. Closing in 15 seconds.